Lv6
2326 积分 2024-05-29 加入
Anti-tumor effectiveness of a novel bispecific antibody that blocks both PD-L1 and LAG-3
4天前
已完结
469 Preclinical studies support clinical development of AZD2936, a monovalent bispecific humanized antibody targeting PD-1 and TIGIT
4天前
求助中
A BIVALENT TIM-3/PD-1 BISPECIFIC ANTIBODY FOR THE TREATMENT OF PD-1 ANTIBODY RESISTANT OR REFRACTORY SOLID TUMORS
5天前
已关闭
461 Generation of AZD7789, a novel PD-1 and TIM-3 targeting bispecific antibody, which binds to a differentiated epitope of TIM-3
5天前
已完结
Trogocytosis of CAR molecule regulates CAR-T cell dysfunction and tumor antigen escape
11天前
已完结
4-1BB costimulation ameliorates T cell exhaustion induced by tonic signaling of chimeric antigen receptors
16天前
已完结
Enhanced CAR T-Cell Therapy for Lymphoma after Previous Failure
25天前
已完结
Enhanced CAR T-Cell Therapy for Lymphoma after Previous Failure
25天前
已完结
Intrathecal bivalent CAR T cells targeting EGFR and IL13Rα2 in recurrent glioblastoma: phase 1 trial interim results
28天前
已完结
Abstract CT078: Phase 1 study of SGN-EGFRd2 in solid tumors (SGNEGFRd2-001)
29天前
已完结
皖公网安备34019202002308
